Project Grant HT94252310915
Award Date
8/31/23
Completion Date
8/30/26
Dollars Obligated
$1.9M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
The University of Washington was awarded a $1,810,550 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 through September 30, 2026 to investigate early chemodenervation of the detrusor muscle to preserve bladder compliance and function over the long term following spinal cord injury. The Military Medical Research and Development program supports basic,...
The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $1,868,800.00 to support research on the effect of cardiocentric hemodynamic management of acutely injured individuals with cervical spinal cord injury on cardiovascular outcomes. The award was granted to the University of British Columbia, a prominent Canadian research university, to conduct this advanced biomedical research initiative over a 3-year period from...
This Project Grant award of $3,834,661 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Washington will fund a 4-year study on nonsurgical kidney stone removal in persons with spinal cord injury. The study aims to develop innovative techniques to improve care and outcomes for this patient population. As the prime recipient, the University of Washington will lead the research activities. No additional details were provided on...
The Washington University Office of Sponsored Research Services Division received a $226,471.00 Project Grant from the Defense Health Agency under the Department of Defense's CFDA 12.420 Military Medical Research and Development program. The grant, awarded on Sep 30, 2023, will fund a study on the "PHOSPHORYLATION TAU PROFILE OF VETERANS WITH TBI" through Sep 29, 2026. As a leading research institution with expertise in biomedical research, the university will leverage its capabilities...
The University of British Columbia (UBC) received a $1,731,421.95 Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) to provide advanced physiologic monitoring at the site of spinal cord injury. The 3-year project, with a start date of September 30, 2023, will focus on transforming healthcare for Service Members and the public through innovative and impactful research into medical solutions for the battlefield. As the...
This federal Project Grant award, worth $2,966,875.00, was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a prospective clinical trial to investigate the optimal timing of surgical decompression for patients with acute spinal cord injuries. The grant recipient, the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, will conduct the research at its facility in Torrance, California over a...
The Defense Health Agency awarded a $3,977,103 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Washington University to conduct a 4-year clinical trial on nerve transfer surgeries to improve upper limb function and quality of life for patients with high-level cervical spinal cord injuries. The study aims to address critical information gaps on the use of nerve transfer procedures in this patient population. The project will be executed through a...
The U.S. Defense Health Agency awarded a $792,500.00 Project Grant to Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University-Of The Commonwealth System Of Higher Educa and doing business as Temple University, for the purpose of "AN EFFECTIVE STRATEGY TO PROMOTE AXON REGENERATION AND FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY". The Project Grant is funded through the U.S. Military Medical Research and Development program (CFDA 12.420),...
The University of Washington received a $617,221 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant funds research to advance the efficacy, longevity, and safety of gene editing therapies for Duchenne muscular dystrophy (DMD). The 2-year grant period runs from August 15, 2023 to August 14, 2025. As a leading research institution, the University of Washington has previously received federal funding to support a...